+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Gut Health Nutraceuticals Market by Product, Form, Distribution Chanel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5910264
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Gut Health Nutraceuticals Market grew from USD 11.29 billion in 2023 to USD 12.07 billion in 2024. It is expected to continue growing at a CAGR of 7.43%, reaching USD 18.65 billion by 2030.

Gut health nutraceuticals encompass dietary products designed to enhance gastrointestinal function and overall well-being. Their scope includes prebiotics, probiotics, synbiotics, and digestive enzymes that support a balanced gut microbiome. The necessity of these products arises from the increasing consumer awareness surrounding digestive health and its links to immunity, mood, and chronic disease prevention. Applications extend to functional foods, dietary supplements, and fortified beverages, targeting end-users across age groups, particularly those with digestive disorders or a proactive approach to health. Market insights highlight factors like rising health consciousness, aging populations, and advancements in microbiome research as growth catalysts. The potential for personalized nutrition and the development of innovative delivery systems such as microencapsulation presents new opportunities. Brands can leverage digital platforms to cater to aware consumers and use insights from gut-brain axis research to expand product lines. Nonetheless, the market faces limitations including stringent regulatory challenges, scientific substantiation demands, and consumer skepticism regarding product efficacy. Navigating these issues requires transparent communication and investment in clinical trials to solidify health claims. Areas ripe for innovation include the exploration of novel strains or combinations, such as postbiotics and bacteriophage therapy, and the integration of AI in personalized nutrition services. Business growth can also stem from tapping into the pet gut health segment and expanding into emerging markets with rising spending capabilities. Despite a competitive landscape, collaboration with academic research institutions can yield breakthrough products and credibility. Remaining agile and responsive to scientific findings and regulatory changes will be crucial for market players to sustain and capture market share. This dynamic sector is characterized by rapid innovation, consumer-driven trends, and a continuous evolution of scientific understanding, suggesting a robust future for gut health nutraceuticals.

Understanding Market Dynamics in the Gut Health Nutraceuticals Market

The Gut Health Nutraceuticals Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing consumer knowledge about the benefits of gut health
    • Rising prevalence of gastrointestinal disorders worldwide
    • Shift towards preventive healthcare and wellness trends
  • Market Restraints
    • Strict government regulations for approvals of gut health nutraceuticals
  • Market Opportunities
    • Potential for personalized nutrition for tailored gut health solutions
    • Deployment of gut health nutraceuticals on eCommerce platforms
  • Market Challenges
    • Skepticism about the efficacy of nutraceutical products

Exploring Porter’s Five Forces for the Gut Health Nutraceuticals Market

Porter’s Five Forces framework further strengthens the insights of the Gut Health Nutraceuticals Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Gut Health Nutraceuticals Market

External macro-environmental factors deeply influence the performance of the Gut Health Nutraceuticals Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Gut Health Nutraceuticals Market

The Gut Health Nutraceuticals Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Gut Health Nutraceuticals Market

The Gut Health Nutraceuticals Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Gut Health Nutraceuticals Market

The Gut Health Nutraceuticals Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gut Health Nutraceuticals Market, highlighting leading vendors and their innovative profiles. These include Alimentary Health Limited, Amway Corporation, Archer-Daniels-Midland Company, BASF SE, Bayer AG, FANCL Corporation, Garden of Life, Glanbia Nutritional, GNC Holdings Inc., HealthForce`, Herbalife Nutrition Ltd., Himalaya Wellness Company, Koninklijke DSM N.V., Lonza Group Ltd, Nestle Health Science S.A., NOW Health Group, Inc., Nutrica NV by Danone S.A., Olly Nutrition, PanTheryx Inc., Pfizer Inc., Sanofi S.A., The Nature's Bounty Co., and Zenwise, LLC.

Market Segmentation & Coverage

This research report categorizes the Gut Health Nutraceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Enzymes
    • Fulvic Acid
    • Prebiotics
    • Probiotics
  • Form
    • Capsules
    • Liquids
    • Powders
    • Tablets
  • Distribution Chanel
    • Offline
    • Online
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing consumer knowledge about the benefits of gut health
5.1.1.2. Rising prevalence of gastrointestinal disorders worldwide
5.1.1.3. Shift towards preventive healthcare and wellness trends
5.1.2. Restraints
5.1.2.1. Strict government regulations for approvals of gut health nutraceuticals
5.1.3. Opportunities
5.1.3.1. Potential for personalized nutrition for tailored gut health solutions
5.1.3.2. Deployment of gut health nutraceuticals on eCommerce platforms
5.1.4. Challenges
5.1.4.1. Skepticism about the efficacy of nutraceutical products
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing preference for probiotics owing to its contribution in balancing gut microbiota
5.2.2. Form: Growing adoption of a tablet form of gut health nutraceuticals due to convenience and durability for storage and transport.
5.2.3. Distribution Chanel: Evolving online distribution channels for gut health nutraceuticals
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Gut Health Nutraceuticals Market, by Product
6.1. Introduction
6.2. Enzymes
6.3. Fulvic Acid
6.4. Prebiotics
6.5. Probiotics
7. Gut Health Nutraceuticals Market, by Form
7.1. Introduction
7.2. Capsules
7.3. Liquids
7.4. Powders
7.5. Tablets
8. Gut Health Nutraceuticals Market, by Distribution Chanel
8.1. Introduction
8.2. Offline
8.3. Online
9. Americas Gut Health Nutraceuticals Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Gut Health Nutraceuticals Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Gut Health Nutraceuticals Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Acutia Launches Holistic Dietary Supplement for Digestive Health In Compostable Packaging
12.3.2. Nestlé Health Science launches ‘Resource Fiber Choice’ to improve gut health
12.3.3. Nutrazee Unveils Probiotic Gummies For Digestive And Immune Health
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. GUT HEALTH NUTRACEUTICALS MARKET RESEARCH PROCESS
FIGURE 2. GUT HEALTH NUTRACEUTICALS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 9. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2023 VS 2030 (%)
FIGURE 11. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. GUT HEALTH NUTRACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. GUT HEALTH NUTRACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. GUT HEALTH NUTRACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GUT HEALTH NUTRACEUTICALS MARKET DYNAMICS
TABLE 7. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FULVIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 30. CANADA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. CANADA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 32. CANADA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 33. MEXICO GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. MEXICO GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 35. MEXICO GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 47. CHINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. CHINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 49. CHINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 50. INDIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. INDIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 52. INDIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 56. JAPAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. JAPAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 58. JAPAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 74. THAILAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. THAILAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 76. THAILAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. DENMARK GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 86. DENMARK GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 87. EGYPT GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. EGYPT GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 89. EGYPT GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 90. FINLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. FINLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 92. FINLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 93. FRANCE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. FRANCE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 95. FRANCE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 96. GERMANY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. GERMANY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 98. GERMANY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 102. ITALY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. ITALY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 104. ITALY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 111. NORWAY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. NORWAY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 113. NORWAY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 114. POLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. POLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 116. POLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 117. QATAR GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. QATAR GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 119. QATAR GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 129. SPAIN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. SPAIN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 131. SPAIN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 138. TURKEY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. TURKEY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 140. TURKEY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
TABLE 147. GUT HEALTH NUTRACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 148. GUT HEALTH NUTRACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Gut Health Nutraceuticals market, which are profiled in this report, include:
  • Alimentary Health Limited
  • Amway Corporation
  • Archer-Daniels-Midland Company
  • BASF SE
  • Bayer AG
  • FANCL Corporation
  • Garden of Life
  • Glanbia Nutritional
  • GNC Holdings Inc.
  • HealthForce`
  • Herbalife Nutrition Ltd.
  • Himalaya Wellness Company
  • Koninklijke DSM N.V.
  • Lonza Group Ltd
  • Nestle Health Science S.A.
  • NOW Health Group, Inc.
  • Nutrica NV by Danone S.A.
  • Olly Nutrition
  • PanTheryx Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • The Nature's Bounty Co.
  • Zenwise, LLC

Methodology

Loading
LOADING...

Table Information